Search research articles
Contact Us
Filters
Showing results (281-290 of 313) with videos related to
Page
of 32
Sort By:
The Lancet. Diabetes & Endocrinology
|
May 27, 2017
10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension
Henry G Bone, Rachel B Wagman, Maria L Brandi, et al.
Joint Bone Spine
|
April 5, 2011
The DESIR cohort: a 10-year follow-up of early inflammatory back pain in France: study design and baseline characteristics of the 708 recruited patients
Maxime Dougados, Maria-Antonietta d'Agostino, Joëlle Benessiano, et al.
The American Journal of Medicine
|
October 25, 2011
Obesity is not protective against fracture in postmenopausal women: GLOW
Juliet E Compston, Nelson B Watts, Roland Chapurlat, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
August 31, 2024
Characterization of flare-ups and impact of garetosmab in adults with fibrodysplasia ossificans progressiva: a post hoc analysis of the randomized, double-blind, placebo-controlled LUMINA-1 trial
Richard Keen, Kathryn M Dahir, Jennifer McGinniss, et al.
Calcified Tissue International
|
October 1, 2013
Obesity, health-care utilization, and health-related quality of life after fracture in postmenopausal women: Global Longitudinal Study of Osteoporosis in Women (GLOW)
Juliet E Compston, Julie Flahive, Frederick H Hooven, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
November 25, 2011
Five years of denosumab exposure in women with postmenopausal osteoporosis: results from the first two years of the FREEDOM extension
Socrates Papapoulos, Roland Chapurlat, Cesar Libanati, et al.
BMJ (Clinical Research Ed.)
|
May 2, 2023
Fracture risk reduction and safety by osteoporosis treatment compared with placebo or active comparator in postmenopausal women: systematic review, network meta-analysis, and meta-regression analysis of randomised clinical trials
Mina Nicole Händel, Isabel Cardoso, Cecilie von Bülow, et al.
The Journal of Clinical Endocrinology and Metabolism
|
August 28, 2013
The effect of three or six years of denosumab exposure in women with postmenopausal osteoporosis: results from the FREEDOM extension
Henry G Bone, Roland Chapurlat, Maria-Luisa Brandi, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
November 25, 2011
Previous fractures at multiple sites increase the risk for subsequent fractures: the Global Longitudinal Study of Osteoporosis in Women
Stephen Gehlbach, Kenneth G Saag, Jonathan D Adachi, et al.
Medicine
|
April 11, 2015
Outcome of hepatitis E virus infection in patients with inflammatory arthritides treated with immunosuppressants: a French retrospective multicenter study
Hélène Bauer, Cécile Luxembourger, Jacques-Eric Gottenberg, et al.
Page
of 32
Search research articles
Search
Showing results (281-290 of 313) with videos related to
Sort By:
Page
of 32
The Lancet. Diabetes & Endocrinology
|
May 27, 2017
10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension
Henry G Bone, Rachel B Wagman, Maria L Brandi, et al.
Joint Bone Spine
|
April 5, 2011
The DESIR cohort: a 10-year follow-up of early inflammatory back pain in France: study design and baseline characteristics of the 708 recruited patients
Maxime Dougados, Maria-Antonietta d'Agostino, Joëlle Benessiano, et al.
The American Journal of Medicine
|
October 25, 2011
Obesity is not protective against fracture in postmenopausal women: GLOW
Juliet E Compston, Nelson B Watts, Roland Chapurlat, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
August 31, 2024
Characterization of flare-ups and impact of garetosmab in adults with fibrodysplasia ossificans progressiva: a post hoc analysis of the randomized, double-blind, placebo-controlled LUMINA-1 trial
Richard Keen, Kathryn M Dahir, Jennifer McGinniss, et al.
Calcified Tissue International
|
October 1, 2013
Obesity, health-care utilization, and health-related quality of life after fracture in postmenopausal women: Global Longitudinal Study of Osteoporosis in Women (GLOW)
Juliet E Compston, Julie Flahive, Frederick H Hooven, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
November 25, 2011
Five years of denosumab exposure in women with postmenopausal osteoporosis: results from the first two years of the FREEDOM extension
Socrates Papapoulos, Roland Chapurlat, Cesar Libanati, et al.
BMJ (Clinical Research Ed.)
|
May 2, 2023
Fracture risk reduction and safety by osteoporosis treatment compared with placebo or active comparator in postmenopausal women: systematic review, network meta-analysis, and meta-regression analysis of randomised clinical trials
Mina Nicole Händel, Isabel Cardoso, Cecilie von Bülow, et al.
The Journal of Clinical Endocrinology and Metabolism
|
August 28, 2013
The effect of three or six years of denosumab exposure in women with postmenopausal osteoporosis: results from the FREEDOM extension
Henry G Bone, Roland Chapurlat, Maria-Luisa Brandi, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
November 25, 2011
Previous fractures at multiple sites increase the risk for subsequent fractures: the Global Longitudinal Study of Osteoporosis in Women
Stephen Gehlbach, Kenneth G Saag, Jonathan D Adachi, et al.
Medicine
|
April 11, 2015
Outcome of hepatitis E virus infection in patients with inflammatory arthritides treated with immunosuppressants: a French retrospective multicenter study
Hélène Bauer, Cécile Luxembourger, Jacques-Eric Gottenberg, et al.
Page
of 32